The Importance of Early Diagnosis and Management of Pediatric Neurogenic Bladder Dysfunction

K Tyler Hobbs, Madison Krischak, Rohit Tejwani, J Todd Purves, John S Wiener, Jonathan C Routh, K Tyler Hobbs, Madison Krischak, Rohit Tejwani, J Todd Purves, John S Wiener, Jonathan C Routh

Abstract

Neurogenic bladder dysfunction is a major source of urologic morbidity in children, especially in those with spina bifida (SB). Complications from progression of bladder dysfunction can include urinary tract infections (UTIs), urinary incontinence, upper tract deterioration, and renal dysfunction or failure. In these children, there has been a recent trend toward proactive rather than expectant management of neurogenic bladder. However, there is a lack of consensus on how to best achieve the three main goals of neurogenic bladder management: 1) preserving kidney function, 2) achieving continence (if desired by the family/individual), and 3) achieving social and functional urologic independence (if appropriate). Hence, our objective was to perform a narrative literature review to evaluate the approaches to diagnosis and management of pediatric neurogenic bladder dysfunction, with special focus on children with SB. The approach strategies vary across a spectrum, with a proactive strategy on one end of the spectrum and an expectant strategy at the other end. The proactive management strategy is characterized by early and frequent labs, imaging, and urodynamic (UDS) evaluation, with early initiation of clean intermittent catheterization (CIC) and proceeding with pharmacotherapy, or surgery if indicated. The expectant management strategy prioritizes surveillance labs and imaging prior to proceeding with invasive assessments and interventions such as UDS or pharmacotherapy. Both treatment strategies are currently utilized and data have historically been inconclusive in demonstrating efficacy of one regimen over the other. We performed a narrative literature evaluating proactive and expectant treatment strategies as they relate to diagnostics and management of Spina Bifida. From the available literature and our practice, a proactive strategy favors greater benefit in preventative management and may decrease risk of renal dysfunction compared with expectant management.

Keywords: bladder dysfunction; diagnosis; management; neurogenic bladder; pediatric; spina bifida.

Conflict of interest statement

Dr Jonathan C Routh is a Consultant for Spina bifida association, outside the submitted work. The authors have no relevant financial and non-financial relationships to the article to disclose.

© 2021 Hobbs et al.

References

    1. Ouyang L, Bolen J, Valdez R, Joseph D, Baum MA, Thibadeau J. Characteristics and survival of patients with end stage renal disease and spina bifida in the United States renal data system. J Urol. 2015;193(2):558–564. doi:10.1016/j.juro.2014.08.092
    1. Routh JC, Joseph DB, Liu T, et al. Bladder Reconstruction Rates Differ among Centers Participating in National Spina Bifida Patient Registry. J Urol. 2018;199(1):268–273. doi:10.1016/j.juro.2017.08.084
    1. Lloyd JC, Wiener JS, Gargollo PC, Inman BA, Ross SS, Routh JC. Contemporary epidemiological trends in complex congenital genitourinary anomalies. J Urol. 2013;190(4 Suppl):1590–1595. doi:10.1016/j.juro.2013.04.034
    1. Parker SE, Mai CT, Canfield MA, et al. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004–2006. Birth Defects Res A Clin Mol Teratol. 2010;88(12):1008–1016. doi:10.1002/bdra.20735
    1. Lee AS, Viseshsindh W, Long CJ, et al. How early is early? Effect of oxybutynin on bladder dynamics within the first year of life in patients with spina bifida. J Pediatr Urol. 2020;16(2):168 e1–168 e6. doi:10.1016/j.jpurol.2019.12.008
    1. Routh JC, Cheng EY, Austin JC, et al. Design and Methodological Considerations of the Centers for Disease Control and Prevention Urologic and Renal Protocol for the Newborn and Young Child with Spina Bifida. J Urol. 2016;196(6):1728–1734. doi:10.1016/j.juro.2016.07.081
    1. Dudley AG, Adams MC, Brock JW 3rd, et al. Interrater Reliability in Interpretation of Neuropathic Pediatric Urodynamic Tracings: an Expanded Multicenter Study. J Urol. 2018;199(5):1337–1343. doi:10.1016/j.juro.2017.12.051
    1. Schechter MS, Liu T, Soe M, Swanson M, Ward E, Thibadeau J. Sociodemographic attributes and spina bifida outcomes. Pediatrics. 2015;135(4):e957–64. doi:10.1542/peds.2014-2576
    1. Joseph DB, Baillie S, Baum MA, Frimberger DC, Khavari R, Misseri R, Tanaka ST, Wood H, Yerkes EB. Urology. Guidelines for the Care of People with Spina Bifida, 4th edition. 2018;162–175.. Avaibale from: . Accessed August 23, 2021.
    1. Wang HH, Lloyd JC, Wiener JS, Routh JC. Nationwide Trends and Variations in Urological Surgical Interventions and Renal Outcome in Patients with Spina Bifida. J Urol. 2016;195(4 Pt 2):1189–1194. doi:10.1016/j.juro.2015.11.033
    1. Edwards AB, Jacobs M. Early Vs. Expectant Management of Spina Bifida Patients-Are We All Talking About a Risk Stratified Approach? Curr Urol Rep. 2019;20(11):76. doi:10.1007/s11934-019-0943-z
    1. Snow-Lisy DC, Yerkes EB, Cheng EY. Update on Urological Management of Spina Bifida from Prenatal Diagnosis to Adulthood. J Urol. 2015;194(2):288–296. doi:10.1016/j.juro.2015.03.107
    1. Bauer SB, Hallett M, Khoshbin S, et al. Predictive value of urodynamic evaluation in newborns with myelodysplasia. JAMA. 1984;252(5):650–652. doi:10.1001/jama.1984.03350050038023
    1. Szymanski KM, Misseri R, Whittam B, Kaefer M, Rink RC, Cain MP. Quantity, Not Frequency, Predicts Bother with Urinary Incontinence and its Impact on Quality of Life in Adults with Spina Bifida. J Urol. 2016;195(4 Pt 2):1263–1269. doi:10.1016/j.juro.2015.07.108
    1. Inouye BM, Jiang R, Alkazemi MH, et al. Hospital and ED charges for spina bifida care in the United States between 2006 and 2014: over $2 billion annually. Disabil Health J. 2019;12(3):431–436. doi:10.1016/j.dhjo.2019.01.007
    1. Dik P, Klijn AJ, van Gool JD. Early Start to Therapy Preserves Kidney Function in Spina Bifida Patients. Eur Urol. 2006;49(5):908–913. doi:10.1016/j.eururo.2005.12.056
    1. Chu DI, Liu T, Patel P, et al. Kidney Function Surveillance in the National Spina Bifida Patient Registry: a Retrospective Cohort Study. J Urol. 2020;204(3):578–586. doi:10.1097/JU.0000000000001010
    1. Stein R, Bogaert G, Dogan HS, et al. EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part I diagnostics and conservative treatment. Neurourol Urodyn. 2020;39(1):45–57. doi:10.1002/nau.24211
    1. Veenboer PW, Hobbelink MG, Ruud Bosch JL, et al. Diagnostic accuracy of Tc-99m DMSA scintigraphy and renal ultrasonography for detecting renal scarring and relative function in patients with spinal dysraphism. Neurourol Urodyn. 2015;34(6):513–518. doi:10.1002/nau.22608
    1. de Kort LM, Bower WF, Swithinbank LV, Marschall-Kehrel D, de Jong TP, Bauer SB. The management of adolescents with neurogenic urinary tract and bowel dysfunction. Neurourol Urodyn. 2012;31(7):1170–1174. doi:10.1002/nau.22206
    1. Gray JAM. Redefining Health Care: creating Value-Based Competition on Results. BMJ. 2006;333(7571):760. doi:10.1136/bmj.333.7571.760
    1. Frimberger D, Cheng E, Kropp BP. The current management of the neurogenic bladder in children with spina bifida. Pediatr Clin North Am. 2012;59(4):757–767. doi:10.1016/j.pcl.2012.05.006
    1. Kaefer M, Pabby A, Kelly M, Darbey M, Bauer SB. Improved bladder function after prophylactic treatment of the high risk neurogenic bladder in newborns with myelomentingocele. J Urol. 1999;162(3 Pt 2):1068–1071. doi:10.1097/00005392-199909000-00031
    1. Parizi JLG, Leal da Cruz M, Andrade MC, et al. A Comparative Analysis of Bladder Pattern of Patients who Underwent In Utero Versus Postnatal Myelomeningocele Repair. J Urol. 2020;203(1):194–199. doi:10.1097/JU.0000000000000521
    1. Kessler TM, Lackner J, Kiss G, Rehder P, Madersbacher H. Early proactive management improves upper urinary tract function and reduces the need for surgery in patients with myelomeningocele. Neurourol Urodyn. 2006;25(7):758–762. doi:10.1002/nau.20304
    1. Teichman JM, Scherz HC, Kim KD, Cho DH, Packer MG, Kaplan GW. An alternative approach to myelodysplasia management: aggressive observation and prompt intervention. J Urol. 1994;152(2 Pt 2):807–811. doi:10.1016/s0022-5347(17)32716-7
    1. Yeung CK, Sreedhar B, Leung VT, Metreweli C. Ultrasound bladder measurements in patients with primary nocturnal enuresis: a urodynamic and treatment outcome correlation. J Urol. 2004;171(6 Pt 2):2589–2594. doi:10.1097/01.ju.0000112978.54300.03
    1. Şekerci ÇA, Işbilen B, Işman F, Akbal C, Şimşek F, Tarcan T. Urinary NGF, TGF-β1, TIMP-2 and bladder wall thickness predict neurourological findings in children with myelodysplasia. J Urol. 2014;191(1):199–205. doi:10.1016/j.juro.2013.08.025
    1. Szymanski KM, Szymanski AJ, Salama AK, Hains DS, Cain MP, Misseri R. Estimating and tracking renal function in children and adults with spina bifida. J Pediatr Urol. 2020;16(2):169–177. doi:10.1016/j.jpurol.2019.12.009
    1. National Clinical Guideline C. National Institute for Health and Clinical Excellence: guidance. Urinary Incontinence in Neurological Disease: management of Lower Urinary Tract Dysfunction in Neurological Disease. Royal College of Physicians (UK) Copyright © 2012, National Clinical Guideline Centre; 2012.
    1. Pham-Huy A, Leonard M, Lepage N, Halton J, Filler G. Measuring glomerular filtration rate with cystatin C and beta-trace protein in children with spina bifida. J Urol. 2003;169(6):2312–2315. doi:10.1097/01.ju.0000060205.23406.13
    1. Yeung CK, Sreedhar B, Leung YF, Sit KY. Correlation between ultrasonographic bladder measurements and urodynamic findings in children with recurrent urinary tract infection. BJU Int. 2007;99(3):651–655. doi:10.1111/j.1464-410X.2006.06580.x
    1. Prakash R, Puri A, Anand R, Jain AK, Lal B, Garg V. Predictors of upper tract damage in pediatric neurogenic bladder. J Pediatr Urol. 2017;13(5):503.e1–503.e7. doi:10.1016/j.jpurol.2017.02.026
    1. Elzeneini W, Waly R, Marshall D, Bailie A. Early start of clean intermittent catheterization versus expectant management in children with spina bifida. J Pediatr Surg. 2019;54(2):322–325. doi:10.1016/j.jpedsurg.2018.10.096
    1. Hopps CV, Kropp KA. Preservation of renal function in children with myelomeningocele managed with basic newborn evaluation and close followup. J Urol. 2003;169(1):305–308. doi:10.1097/01.ju.0000040590.35948.bc
    1. Lapides J, Diokno AC, Silber SJ, Lowe BS. Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol. 1972;107(3):458–461. doi:10.1016/s0022-5347(17)61055-3
    1. Verpoorten C, Buyse GM. The neurogenic bladder: medical treatment. Article. Pediatr Nephrol. 2008;23:717. doi:10.1007/s00467-007-0691-z
    1. Liu T, Ouyang L, Thibadeau J, et al. Longitudinal Study of Bladder Continence in Patients with Spina Bifida in the National Spina Bifida Patient Registry. J Urol. 2018;199(3):837–843. doi:10.1016/j.juro.2017.11.048
    1. Lee B, Featherstone N, Nagappan P, McCarthy L, O’Toole S. British Association of Paediatric Urologists consensus statement on the management of the neuropathic bladder. J Pediatr Urol. 2016;12(2):76–87. doi:10.1016/j.jpurol.2016.01.002
    1. Wu HY, Baskin LS, Kogan BA. Neurogenic bladder dysfunction due to myelomeningocele: neonatal versus childhood treatment. J Urol. 1997;157(6):2295–2297. doi:10.1016/S0022-5347(01)64766-9
    1. Nguyen M, Pavlock C, Zderic S, Carr M, Canning D. Overnight catheter drainage in children with poorly compliant bladders improves post-obstructive diuresis and urinary incontinence. J Urol. 2005;174:1633–6; discussion 1636. doi:10.1097/01.ju.0000179394.57859.9d
    1. Edelstein RA, Bauer SB, Kelly MD, et al. The long-term urological response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy. J Urol. 1995;154(4):1500–1504. doi:10.1016/S0022-5347(01)66914-3
    1. Kaye IY, Payan M, Vemulakonda VM. Association between clean intermittent catheterization and urinary tract infection in infants and toddlers with spina bifida. J Pediatr Urol. 2016;12(5):284.e1–284.e6. doi:10.1016/j.jpurol.2016.02.010
    1. Reid SM, Westbury C, Guzys AT, Reddihough DS. Anticholinergic medications for reducing drooling in children with developmental disability. Dev Med Child Neurol. 2020;62(3):346–353. doi:10.1111/dmcn.14350
    1. Çetinel B, Önal B, Can G, Talat Z, Erhan B, Gündüz B. Risk factors predicting upper urinary tract deterioration in patients with spinal cord injury: a retrospective study. Neurourol Urodyn. 2017;36(3):653–658. doi:10.1002/nau.22984
    1. Gamé X, Mouracade P, Chartier-Kastler E, et al. Botulinum toxin-A (Botox®) intradetrusor injections in children with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. J Pediatr Urol. 2009;5(3):156–164. doi:10.1016/j.jpurol.2009.01.005
    1. Kask M, Rintala R, Taskinen S. Effect of onabotulinumtoxinA treatment on symptoms and urodynamic findings in pediatric neurogenic bladder. J Pediatr Urol. 2014;10(2):280–283. doi:10.1016/j.jpurol.2013.09.004
    1. Scales CD Jr, Wiener JS. Evaluating outcomes of enterocystoplasty in patients with spina bifida: a review of the literature. J Urol. 2008;180(6):2323–2329. doi:10.1016/j.juro.2008.08.050
    1. Wiener JS, Antonelli J, Shea AM, et al. Bladder augmentation versus urinary diversion in patients with spina bifida in the United States. J Urol. 2011;186(1):161–165. doi:10.1016/j.juro.2011.03.023
    1. Tradewell M, Pariser JJ, Nimeh T, Elliott SP. Neurogenic Bladder Research G. Systematic review and practice policy statements on urinary tract infection prevention in adults with spina bifida. Transl Androl Urol. 2018;7(Suppl 2):S205–S219. doi:10.21037/tau.2018.04.21

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe